-
Gammagard®
Gammagard® is an intravenous immunoglobulin (IVIG) therapy made from pooled human plasma that contains antibodies essential for immune function. At Singlepoint Healthcare, we offer Gammagard® IV Therapy as part of a comprehensive, coordinated approach to help patients manage symptoms, stabilize disease activity, and improve overall quality of life in a safe and supportive environment.
What is Gammagard?
Symptoms such as fatigue, weakness, numbness, or recurrent infections can interfere with daily life and long-term well-being. IVIG therapies such as Gammagard® support or regulate the immune system, depending on the condition being treated.
By helping to normalize immune responses, Gammagard® can reduce inflammation, prevent immune-related nerve damage, and lower the risk of complications associated with immune dysfunction. Treatment is delivered through an IV infusion under the supervision of trained healthcare professionals.
Key Details
Important Information
| Category | Details |
|---|---|
| Conditions It Treats | Primary Immunodeficiency (PI), Multifocal Motor Neuropathy (MMN), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
| Manufacturer | Takeda |
| Administered by | Infusion |
| Frequency | 3 to 4 weeks |
| Length of Infusion | ~2 hours |
| FDA Approval(s) | Approved for multiple immune deficiency and autoimmune indications |